Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 20/12/21 → 19/12/26 |
Keywords
- phase 1 study
- multicentre trial
- solid tumour
- treatment safety
- treatment efficacy
Clinical Trial Phase
- Phase I
A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, PK, and Efficacy of MK-1084 as Monotherapy and in Combination with Pembrolizumab in Subjects with KRASG12C Mutant Advanced Solid Tumors
- Ahern, Elizabeth (Primary Chief Investigator (PCI))
Project: Research